Cubist Systematic Strategies’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
DSCM
SFM
AC
SBH
Cubist Systematic Strategies's ANGO Position: Q2 2025 in Review
Cubist Systematic Strategies sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 232,473 shares — an estimated $2.18M sold.
Cubist Systematic Strategies first reported a position in ANGO in Q2 2014 and held it in 24 quarters. The position peaked at $2.96M in Q3 2023. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.
- Cubist Systematic Strategies reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
- Cubist Systematic Strategies sold 232,473 AngioDynamics shares in Q2 2025, an estimated $2.18M.
- Cubist Systematic Strategies first reported a position in AngioDynamics in Q2 2014 and held it in 24 quarters.
- Cubist Systematic Strategies's AngioDynamics position peaked at $2.96M in Q3 2023.
- 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.
Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.